Letroz contains Letrozole, an oral hormonal anticancer medicine belonging to the aromatase inhibitor class. Letrozole reduces the production of estrogen in the body by inhibiting the aromatase enzyme. Lower estrogen levels can slow or inhibit the growth of hormone-sensitive breast cancer cells.

Letrozole is primarily used for the treatment of hormone receptor-positive breast cancer in postmenopausal women and may be prescribed in different treatment settings depending on the patient’s disease and treatment history.

What is Letrozole?

Letrozole is a non-steroidal aromatase inhibitor used as hormonal therapy for certain breast cancers.

It works by inhibiting the aromatase enzyme, which is involved in the conversion of androgens into estrogen. Reducing estrogen availability can help slow the growth of estrogen-dependent breast cancer cells.

Benefits and Uses of Letroz

Letroz (Letrozole) may be prescribed for:

• Treatment of hormone receptor-positive breast cancer
• Treatment of certain breast cancers in postmenopausal women
• Adjuvant treatment following initial breast-cancer therapy
• Extended adjuvant hormonal therapy in selected patients
• Treatment of advanced or metastatic hormone-sensitive breast cancer
• Reduction of estrogen production through aromatase inhibition

The appropriate treatment duration and use depend on the patient’s menopausal status, cancer characteristics, previous treatment, and clinical assessment.

Dosage Guidelines

The dosage of Letrozole should be determined by the treating physician based on the patient’s diagnosis and treatment plan.

• Letrozole is commonly administered once daily.
• It may generally be taken with or without food.
• Take Letroz at approximately the same time each day.
• Swallow the tablet with water.
• Continue treatment for the duration prescribed by the healthcare professional.
• Do not stop or change the dose without medical advice.

Long-term treatment may require monitoring of bone health, cholesterol levels, and other clinically relevant parameters.

Wholesale & Supply

Onco India International can support wholesale and bulk pharmaceutical supply of Letroz (Letrozole) for eligible markets and pharmaceutical procurement requirements.

Bulk supply may be suitable for:

• Pharmaceutical distributors
• Hospitals and healthcare institutions
• Oncology distributors
• International pharmaceutical buyers
• Licensed importers and exporters
• Healthcare procurement organizations

Packaging, minimum order quantities, documentation, and availability may vary according to market requirements.

Buying Letrozole Online

When sourcing Letroz or other Letrozole products, buyers should verify the strength, dosage form, manufacturer, batch information, packaging, and applicable quality documentation.

Letrozole is a prescription hormonal anticancer medicine. Pharmaceutical products should be obtained through authorized and appropriately licensed suppliers and used under qualified medical supervision.

Reviews

Individual responses to Letrozole can vary depending on hormone-receptor status, cancer stage, treatment history, duration of therapy, and patient-specific factors.

For pharmaceutical procurement, important considerations include product quality, manufacturing standards, documentation, packaging integrity, and supply reliability.

Quality Assurance

Quality assurance is essential for hormonal oncology medicines such as Letrozole. Products should be manufactured, tested, packaged, and stored according to applicable pharmaceutical quality and regulatory requirements.

Relevant documentation, including available product specifications, certificates, batch information, and package inserts, can be requested where applicable.

Frequently Asked Questions

What is Letroz used for?

Letroz contains Letrozole and is primarily used for the treatment of certain hormone receptor-positive breast cancers, particularly in postmenopausal women.

What type of medicine is Letrozole?

Letrozole is a non-steroidal aromatase inhibitor and hormonal anticancer medicine.

How does Letrozole work?

Letrozole inhibits the aromatase enzyme, reducing estrogen production. This can slow the growth of breast cancer cells that depend on estrogen signaling.

Is Letrozole a chemotherapy medicine?

No. Letrozole is classified as hormonal therapy, specifically an aromatase inhibitor, rather than conventional cytotoxic chemotherapy.

Who is Letrozole commonly prescribed for?

Letrozole is commonly prescribed for postmenopausal women with hormone receptor-positive breast cancer, although its use depends on the specific clinical situation.

How is Letrozole administered?

Letrozole is taken orally, generally once daily, with or without food, according to the prescribed treatment regimen.

What are common side effects of Letrozole?

Possible adverse effects include hot flashes, sweating, joint or muscle pain, fatigue, headache, nausea, and changes in bone mineral density. Individual responses vary.

Can Letrozole affect bone health?

Yes. Because estrogen levels are reduced, long-term Letrozole treatment can contribute to bone loss and increased fracture risk. Healthcare professionals may monitor bone health when appropriate.

Does Letrozole require regular monitoring?

Depending on the treatment plan, physicians may monitor bone health, cholesterol levels, treatment response, and other relevant clinical parameters.

Conclusion

Letroz (Letrozole) is an oral aromatase inhibitor used as hormonal therapy for selected hormone receptor-positive breast cancers, particularly in postmenopausal women. By reducing estrogen production, Letrozole can help inhibit the growth of estrogen-dependent breast cancer cells.

Because treatment duration and suitability depend on the patient’s cancer characteristics and treatment history, Letrozole should be prescribed and monitored by a qualified oncology professional.